Back
Akero Therapeutics Stock Price Chart
![](/images/offers/ims/large/offer18.jpg)
Free video reveals how to trade 1-day options
Get the free overnight options training here.
Buy
69
AKRO
Akero Therapeutics
Last Price:
22.40
Seasonality Move:
56.48%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer17.jpg)
A Silent Invasion of America
Click here to see what you can do to make sure you're not left behind.- The current trend is moderately bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.
Akero Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.16 | Sell |
20-day SMA: | 22.66 | Buy |
50-day SMA: | 21.11 | Buy |
200-day SMA: | 23.32 | Sell |
8-day EMA: | 23.2 | Sell |
20-day EMA: | 22.59 | Buy |
50-day EMA: | 22.06 | Buy |
200-day EMA: | 25.28 | Sell |
Akero Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.66 | Buy |
Relative Strength Index (14 RSI): | 55.44 | Buy |
Chaikin Money Flow: | -646992 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.8 - 23.94) | Buy |
Bollinger Bands (100): | (19.69 - 25.97) | Buy |
Akero Therapeutics Technical Analysis
Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Akero Therapeutics Stock
Is Akero Therapeutics Stock a Buy?
- Akero Therapeutics share price is 23.16 while AKRO 8-day simple moving average is 23.16, which is a Sell signal.
- The stock price of AKRO is 23.16 while Akero Therapeutics 20-day SMA is 22.66, which makes it a Buy.
- Akero Therapeutics 50-day simple moving average is 21.11 while AKRO share price is 23.16, making it a Buy technically.
- AKRO stock price is 23.16 and Akero Therapeutics 200-day simple moving average is 23.32, creating a Sell signal.
AKRO Technical Analysis vs Fundamental Analysis
Buy
69
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy or a Sell?
-
Akero Therapeutics stock is rated a Buy
The current Akero Therapeutics [AKRO] share price is $23.16. The Score for AKRO is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
Akero Therapeutics Stock Info
Market Cap:
1.6B
Price in USD:
23.16
Share Volume:
672.36K
Akero Therapeutics 52-Week Range
52-Week High:
53.77
52-Week Low:
11.25
Buy
69
Akero Therapeutics (AKRO)
is a Buy
Akero Therapeutics Share Price Forecast
-
What is the Akero Therapeutics stock price today?
The Akero Therapeutics stock price is 23.16 USD today. -
Will AKRO stock go up or go down?
Akero Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Akero Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akero Therapeutics is not overvalued.
Is Akero Therapeutics Stock a Buy?
- Akero Therapeutics share price is 23.16 while AKRO 8-day exponential moving average is 23.20, which is a Sell signal.
- The stock price of AKRO is 23.16 while Akero Therapeutics 20-day EMA is 22.59, which makes it a Buy.
- Akero Therapeutics 50-day exponential moving average is 22.06 while AKRO share price is 23.16, making it a Buy technically.
- AKRO stock price is 23.16 and Akero Therapeutics 200-day simple moving average is 25.28, creating a Sell signal.
Fundamental Analysis of Akero Therapeutics
Is Akero Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.18 per share, a decrease this year of $0.83 per share, and a decrease next year of $0.65 per share.
Technical Analysis of Akero Therapeutics
Should I short Akero Therapeutics stock?
- AKRO Moving Average Covergence Divergence (MACD) indicator is 0.66, suggesting Akero Therapeutics is a Buy
- Akero Therapeutics Relative Strength Index (RSI) is 55.44, which suggest Akero Therapeutics is overbought
- The Bollinger Bands (25) for Akero Therapeutics is (19.8 - 23.94), which suggest Akero Therapeutics is a Buy
- The Bollinger Bands (100) for Akero Therapeutics is (19.69 - 25.97), which suggest Akero Therapeutics is a Buy
* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.